HONG KONG – Hong Kong Exchanges and Clearing Limited (HKEX) posted HK$8.78 billion ($1.13 billion) of revenue and other income in the first half of the year, up 2 percent, and a net profit of HK$5.23 billion, up 1 percent year-on-year.

Average daily turnover in the securities market stood at HK$117.5 billion, increased by 20 percent from the year before, HKEX said on Wednesday.

The bourse had a very good first half against a turbulent and volatile macro economic backdrop, said its chief executive Charles Li.

“High cash market turnover, record Stock Connect volumes and a notable number of IPOs, including a number of sizable secondary listings, offset softness in investment income which was impacted by swings in global portfolio valuations during the period,” he said in a statement.

Shares fell by 1.42 percent to close at HK$373.6 per share on Wednesday. 

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Foot Locker rides pent up demand, US pandemic assistance

Foot Locker expects to turn a second-quarter profit thanks in part to aid sent to Americans to help during the pandemic. The announcement caught Wall Street, which had expected big losses from the retailer, by surprise Monday. Shares jumped 6%.…

Shanghai port sees container throughput hit record high in July

SHANGHAI — The container throughput of Shanghai port exceeded 3.9 million TEUs in July, hitting a record high, according to Shanghai International Port (Group) Co Ltd (SIPG). The port saw its container throughput total 149,565 TEUs on Thursday, representing a…

U.S. health insurers may balk at paying for coronavirus antibody testing

NEW YORK (Reuters) – U.S. health insurers may balk at covering tests that look for coronavirus antibodies in some cases, arguing that employers or the government should foot a bill expected to run into billions of dollars. Health insurers have…

The vaccine news is great for most stocks — unless you’re Zoom

New York (CNN Business)Stocks were already set to soar Monday after Joe Biden was elected 46th US president — but Wall Street’s enthusiasm kicked into an even higher gear after Pfizer and BioNTech announced positive clinical data for their Covid-19…